Full Text View
Tabular View
No Study Results Posted
Related Studies
Multicenter Trial of Prednisone in Alzheimer's Disease
This study has been completed.
Study NCT00000178   Information provided by National Institute on Aging (NIA)
First Received: October 29, 1999   Last Updated: June 23, 2005   History of Changes

October 29, 1999
June 23, 2005
 
 
 
 
Complete list of historical versions of study NCT00000178 on ClinicalTrials.gov Archive Site
 
 
 
Multicenter Trial of Prednisone in Alzheimer's Disease
Multicenter Trial of Prednisone in Alzheimer's Disease

This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or a placebo. Neither the patients nor the participating investigators will know who is receiving the drugs and who is receiving the placebo. Participation involves 15 outpatient clinic visits over a 68 week period. Patients take study medication at varying doses (the maximum dose is 20 mg daily), along with calcium and vitamin supplements.

 
Phase III
Interventional
Treatment, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study
Alzheimer Disease
Drug: Prednisone
 
Aisen PS, Davis KL, Berg JD, Schafer K, Campbell K, Thomas RG, Weiner MF, Farlow MR, Sano M, Grundman M, Thal LJ. A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology. 2000 Feb 8;54(3):588-93.

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
 
 

Inclusion Criteria:

  • Patients with Alzheimer's disease who are in stable medical condition

Exclusion Criteria:

  • Patients with diabetes or severe osteoporosis
Both
 
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000178
 
IA0002, 3U01AG10483-08S2
National Institute on Aging (NIA)
 
Principal Investigator: Leon Thal, MD. University of California, San Diego
National Institute on Aging (NIA)
February 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP